Back to Results

VA Protocol: Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

Study category: Behaviors and Mental Health

Is this Study for You?

Let's Get Started!

Description

Adults diagnosed with schizophrenia are needed for a clinical trial to learn more about how a new medication may affect the brain. Study participants will complete MRI scans, clinical interviews, and cognitive tests. Duration of participation: 14 weeks. Participants will be compensated for their time.

Details
Age

Adult

Eligibility

Volunteers must have a diagnosis of schizophrenia or schizoaffective disorder.

Volunteers must be between 18-70 years old, have a diagnosis of schizophrenia or schizoaffective disorder, not have metal or electronic devices in their body and not be claustrophobic.

Type of Study

Treatment

Locations

Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Jason Tregellas,  PhD

Jason Tregellas, PhD

Study ID

Protocol Number: 16-1831

More information available at ClinicalTrials.gov: NCT03034356

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers